NCT01156584 2018-05-21A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant GliomaTocagen Inc.Phase 1 Completed54 enrolled
NCT00186862 2008-06-03Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory NeuroblastomaSt. Jude Children's Research HospitalPhase 1 Completed24 enrolled